Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amarin Corporation plc (AMRN)

1.22   0.03 (2.52%) 12-02 16:00
Open: 1.16 Pre. Close: 1.19
High: 1.23 Low: 1.16
Volume: 1,143,157 Market Cap: 493(M)

Technical analysis

as of: 2022-12-02 4:20:52 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.49     One year: 1.61
Support: Support1: 1.12    Support2: 0.93
Resistance: Resistance1: 1.28    Resistance2: 1.37
Pivot: 1.19
Moving Average: MA(5): 1.16     MA(20): 1.21
MA(100): 1.26     MA(250): 2.12
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 26.6     %D(3): 16.3
RSI: RSI(14): 52.4
52-week: High: 3.81  Low: 1.03
Average Vol(K): 3-Month: 2,529 (K)  10-Days: 1,857 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AMRN ] has closed below upper band by 40.2%. Bollinger Bands are 33.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.23 - 1.23 1.23 - 1.24
Low: 1.15 - 1.15 1.15 - 1.16
Close: 1.21 - 1.22 1.22 - 1.23

Company Description

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Headline News

Thu, 01 Dec 2022
Should You Buy Amarin Corporation plc (AMRN) Stock After it Has Gained 0.85% in a Week? - InvestorsObserver

Thu, 24 Nov 2022
BRIEF—Amarin names new head of UK business to lead growth - The Pharma Letter

Mon, 21 Nov 2022
Why Amarin (AMRN) Stock Might be a Great Pick - Nasdaq

Wed, 16 Nov 2022
Amarin Corporation plc (AMRN) Management Presents at 13th Annual Jefferies London Healthcare Conference 2022 (Transcript) - Seeking Alpha

Tue, 15 Nov 2022
Why Amarin Stock Was a Winner Today - The Motley Fool

Wed, 09 Nov 2022
Amarin Co. plc (NASDAQ:AMRN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 404 (M)
Shares Float 373 (M)
% Held by Insiders 1.2 (%)
% Held by Institutions 33.3 (%)
Shares Short 10,130 (K)
Shares Short P.Month 8,830 (K)

Stock Financials

EPS -0.06
EPS Est Next Qtl -0.03
EPS Est This Year -0.21
EPS Est Next Year -0.06
Book Value (p.s.) 1.46
Profit Margin (%) -21.8
Operating Margin (%) -11.6
Return on Assets (ttm) -3.2
Return on Equity (ttm) -15
Qtrly Rev. Growth -36.8
Gross Profit (p.s.) 1.14
Sales Per Share 1.04
EBITDA (p.s.) -0.12
Qtrly Earnings Growth 0
Operating Cash Flow -210 (M)
Levered Free Cash Flow 27 (M)

Stock Valuations

PE Ratio -21.79
PEG Ratio -0.2
Price to Book value 0.83
Price to Sales 1.16
Price to Cash Flow -2.35

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.